… marginal opportunity costs of health services. The components of the costs of caring for COPD
patients considered in this study were 1) direct costs of health services, 2) indirect costs of …

… reviews of ILD disease cost studies and cost-… costs between countries according to the
share of costs towards each country’s respective gross domestic product (GDP) per capita. Costs …

… the cost-effectiveness of palivizumab as RSV prophylaxis in premature infants without chronic
lung disease and to evaluate the impact on cost-… estimates of the efficacy of palivizumab in …

… lung biopsy for interstitial lung disease (ILD) is currently limited. Transbronchial cryobiopsy
via flexible bronchoscope may this for more patients. The relative costs, … ) surgical lung biopsy …

… diseases [2–6]. In this review, we will discuss the postulated burden of interstitial lung diseases
(… This amount was estimated prior to approval and utilisation of efficacious targeted IPF …

… of cost-effectiveness, as well as clinical benefit, before adopting new technologies. This
analysis used a validated COPD disease-progression model [15,16] and applied efficacy and …

… The current analysis was conducted using the GALAXY-COPD disease progression model,
which … Cost, efficacy and utility inputs were varied to the upper and lower bounds of the range …

… the cost-effectiveness of HRCT screening based on disease … diffuse cystic lung diseases
remains cost effective at disease … However, the efficacy of a low-dose chest CT scan in the …

… N acetylcysteine greater than 600 mg might have produced clearer effects on pulmonary
function; a dose of 1800 mg per day improved lung function in a study of interstitial lung disease …

… existing estimates, the direct medical costs associated with managing NTMLD are thought to
… -makers, we sought to estimate the cost of MAC lung disease in Canada, France, Germany …